Penumbra, Inc. Reports First Quarter 2024 Financial Results

ALAMEDA, Calif., May 7, 2024 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024. Revenue of $278.7 million in the first quarter of 2024, an increase of 15.4%…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks